↓ Skip to main content

Current strategies for identifying and validating targets for new treatment-shortening drugs for TB.

Overview of attention for article published in Current Molecular Medicine, May 2007
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
2 patents

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Current strategies for identifying and validating targets for new treatment-shortening drugs for TB.
Published in
Current Molecular Medicine, May 2007
DOI 10.2174/156652407780598575
Pubmed ID
Authors

Kerstin J Williams, Ken Duncan

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
India 1 3%
Gambia 1 3%
Argentina 1 3%
Unknown 32 91%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 9 26%
Researcher 6 17%
Other 5 14%
Professor 3 9%
Student > Bachelor 2 6%
Other 5 14%
Unknown 5 14%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 15 43%
Chemistry 5 14%
Biochemistry, Genetics and Molecular Biology 4 11%
Medicine and Dentistry 4 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 0 0%
Unknown 6 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 September 2015.
All research outputs
#7,582,553
of 34,365,356 outputs
Outputs from Current Molecular Medicine
#196
of 916 outputs
Outputs of similar age
#28,408
of 126,604 outputs
Outputs of similar age from Current Molecular Medicine
#1
of 8 outputs
Altmetric has tracked 34,365,356 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 916 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 126,604 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them